-
Arrowhead Increases Investment in Calando Pharmaceuticals
Tuesday, January 18, 2011 - 8:58am | 46Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted approximately $8M of Calando debt to Arrowhead into equity. Arrowhead now owns approximately 79% of Calando's outstanding equity.
-
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, AXK, BLUD, VIVO)
Tuesday, January 18, 2011 - 4:22am | 128Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 59.32%. TRIB's PEG ratio is 1.60. The trailing-twelve-month profit margin at Accelr8 Technology...
-
Thermo Fisher Extends Dionex Offer - Analyst Blog
Monday, January 17, 2011 - 10:01am | 442Thermo Fisher Scientific (TMO) has extended the tender offer to acquire shares of Dionex Corporation (DNEX) till February 16, 2011. However, the other conditions remain unchanged. Last week, the company received antitrust clearance with respect to the acquisition. Thermo Fisher is in the process...
-
Thermo Fisher Extends Dionex Offer - Analyst Blog
Monday, January 17, 2011 - 9:30am | 442Thermo Fisher Scientific (TMO) has extended the tender offer to acquire shares of Dionex Corporation (DNEX) till February 16, 2011. However, the other conditions remain unchanged. Last week, the company received antitrust clearance with respect to the acquisition. Thermo Fisher is in the process...
-
Compugen Up 9.8% After Hitting 52-Week High (CGEN)
Friday, January 14, 2011 - 3:33pm | 165Shares of Compugen Ltd. (Nasdaq: CGEN) are trading up 9.8% at $5.60 per share during the Friday afternoon trading session. The day's trading range for shares of Compugen Ltd has been between $5.09 and a 52-week high of $5.77 per share. Trading volume for Compugen Ltd. (CGEN) has been extremely...
-
Affymetrix Posts 4Q View, Inks Deal - Analyst Blog
Friday, January 14, 2011 - 2:01pm | 530Genetic products maker Affymetrix Inc (AFFX) has announced its expected results for fourth-quarter fiscal 2010. Separately, the California-based company has entered into a distribution pact with Fischer Scientific Inc, a unit of Thermo Fisher Scientific (TMO). Affymetrix's shares gained roughly...
-
Affymetrix Posts 4Q View, Inks Deal - Analyst Blog
Friday, January 14, 2011 - 1:15pm | 530Genetic products maker Affymetrix Inc (AFFX) has announced its expected results for fourth-quarter fiscal 2010. Separately, the California-based company has entered into a distribution pact with Fischer Scientific Inc, a unit of Thermo Fisher Scientific (TMO). Affymetrix's shares gained roughly...
-
Good News for Cumberland Pharma - Analyst Blog
Friday, January 14, 2011 - 12:31pm | 539Recently, Cumberland Pharmaceuticals Inc. (CPIX) received a boost when the US Food and Drug Administration (FDA) cleared a new formulation of the company's liver drug Acetadote. The injectable drug has been approved to counteract overdoses of acetaminophen and finds application in hospitals for...
-
Puts Purchased on Covance Inc. (CVD)
Friday, January 14, 2011 - 12:12pm | 125Shares of Covance Inc. (NYSE: CVD) are lower on the session by 0.26%, currently trading at $54.46. The stock has been moving largely higher over the past five months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short...
-
Good News for Cumberland Pharma - Analyst Blog
Friday, January 14, 2011 - 12:00pm | 539Recently, Cumberland Pharmaceuticals Inc. (CPIX) received a boost when the US Food and Drug Administration (FDA) cleared a new formulation of the company's liver drug Acetadote. The injectable drug has been approved to counteract overdoses of acetaminophen and finds application in hospitals for...
-
Piper Jaffray's Top Picks For Medical Diagnostics
Friday, January 14, 2011 - 9:47am | 188Piper Jaffray has published a research report on Medical Diagnostics, writing "Our positive 4Q10 STD channel checks suggest a combination of a deductible flush and easier H1N1 comps in December. Not surprisingly, there is concern about the effect of resetting deductibles on 1Q11 trends. We believe...
-
Calls Purchased on Affymetrix, Inc. (AFFX)
Thursday, January 13, 2011 - 2:21pm | 138Shares of Affymetrix, Inc. (NASDAQ: AFFX) are lower on the session by 2.77%, currently trading at $5.26. The stock has been moving largely higher over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A...
-
Caliper Life Sciences Up 7.3% On Preliminary Results (CALP)
Thursday, January 13, 2011 - 2:18pm | 183Shares of Caliper Life Sciences Inc. (Nasdaq: CALP) are trading up 7.3% at $6.05 per share during the Thursday afternoon trading session. On Thursday morning before the market opened, the company announced preliminary 4th quarter revenue results of $36.0 million, which exceeded the upper end of its...
-
Best Biotech Stocks To Own Now (CRIS, CGEN, SPPI, IPXL)
Thursday, January 13, 2011 - 11:27am | 193Marketwatch has a list of five biotech stocks to own now, for a wide variety of reasons. The four names the author mentions are Cerus (NASDAQ: CERS), Curis (NASDAQ: CRIS), Compugen (NASDAQ: CGEN), Spectrum Pharmaceuticals (NASDAQ: SPPI), and Impax Laboratories (NASDAQ: IPXL). Regarding Cerus, the...
-
Merck & Parexel Enter Pact - Analyst Blog
Thursday, January 13, 2011 - 11:01am | 458Merck & Co. Inc. (MRK) recently entered into an agreement with Parexel International Corporation (PRXL). Per the terms of the deal, Merck BioVentures (a division of Merck) will have access to Parexel's range of regulatory, strategic and clinical development planning capabilities for the...